Coldstream Capital Management Inc Kal Vista Pharmaceuticals, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KALV
# of Institutions
139Shares Held
53.4MCall Options Held
1.38MPut Options Held
6K-
Vr Adviser, LLC New York, NY6.7MShares$86.5 Million18.68% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$63.8 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$63.4 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$63.1 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$61.3 Million3.92% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $318M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...